David C. Goldberg
2012 - Enzo Biochem
In 2012, David C. Goldberg earned a total compensation of $330.4K as Vice President Corporate Development and Interim General Manager, Enzo Clinical Labs at Enzo Biochem, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $70,000 |
|---|---|
| Salary | $208,076 |
| Stock Awards | $24,600 |
| Other | $27,711 |
| Total | $330,387 |
Goldberg received $208.1K in salary, accounting for 63% of the total pay in 2012.
Goldberg also received $70K in non-equity incentive plan, $24.6K in stock awards and $27.7K in other compensation.
Rankings
In 2012, David C. Goldberg's compensation ranked 9,909th out of 11,487 executives tracked by ExecPay. In other words, Goldberg earned more than 13.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,909 out of 11,487 | 14th |
Division Services | 1,494 out of 1,721 | 13th |
Major group Health Services | 153 out of 167 | 8th |
Industry group Medical And Dental Laboratories | 37 out of 41 | 10th |
Industry Medical Laboratories | 37 out of 41 | 10th |
Source: SEC filing on November 26, 2014.
Goldberg's colleagues
We found four more compensation records of executives who worked with David C. Goldberg at Enzo Biochem in 2012.